Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02681731 · ClinicalTrials.gov registry record
Impact of Neuromonitoring During Cardiac Procedures
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 250,000
- Enrollment target
NCT02681731 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 250,000 participants.
The verdict
NCT02681731 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 250,000 participants
- Enrollment target
Study Summary
Through a series of sequential analyses, retrospective database exploration looking for linkages and associations between the use of processed electroencephalogram (EEG) and/or cerebral saturation monitoring and patient outcomes post-cardiothoracic surgery will be explored.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250,000 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02681731
The ClinicalTrials.gov registry entry for NCT02681731 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02681731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02681731 about?
NCT02681731 is a clinical study titled "Impact of Neuromonitoring During Cardiac Procedures". Through a series of sequential analyses, retrospective database exploration looking for linkages and associations between the use of processed electroencephalogram (EEG) and/or cerebral saturation monitoring and patient outcomes post-cardiothoracic surgery will be explored.
What is the current status of trial NCT02681731?
This trial is currently completed. The enrollment target is 250,000 participants. The study started on 2016-03. Estimated completion is 2017-12-31.
Who is sponsoring clinical trial NCT02681731?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.